Ondine Biopharma Corporation (the "Company") is pleased to announce that it has closed on its previously announced brokered private placement of 1,000,000 common shares (the "Shares") at a price of $1.00 per share for gross proceeds of $1,000,000. The Shares are subject to a four-month hold period expiring September 12, 2004.
